T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
T2 Biosystems, Inc. (TTOO) announced a conference call to discuss T2Lyme Panel launch plans and business updates. The call will be held on March 20, 2024, at 8:30 a.m. Eastern Time. Investors can access the webcast at www.t2biosystems.com.
03/19/2024 - 09:00 AM
LEXINGTON, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that Company management will host a conference call to discuss the T2Lyme Panel launch plans and provide additional business updates before market open on Wednesday, March 20, 2024 beginning at 8:30 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com
About T2 Biosystems ® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2Biothreat™ Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR® ) technology. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the Candida auris test, and the T2Lyme™ Panel. For more information, please visit www.t2biosystems.com
Investor Contact: ir@T2Biosystems.com
When will T2 Biosystems host a conference call to discuss T2Lyme Panel launch plans?
T2 Biosystems will host a conference call on March 20, 2024, at 8:30 a.m. Eastern Time.
Where can investors access the webcast of the conference call?
Investors can access the webcast at www.t2biosystems.com on the Investors page in the Events & Presentations section.
What is the dial-in number for the conference call?
The dial-in number for the conference call is 1-888-506-0062 (U.S./Canada) or 1-973-528-0011 (International), passcode 688651.
TTOO Rankings
#5524 Ranked by Stock Gains
TTOO Stock Data
Industry
Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Country
US
City
Lexington
About TTOO
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
